NVAX – Novavax, Inc.
NVAX
$6.19Name : Novavax, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,002,594,304.00
EPSttm : 2.75
Novavax, Inc.
$6.19
Float Short %
28.68
Margin Of Safety %
Put/Call OI Ratio
0.72
EPS Next Q Diff
-3.14
EPS Last/This Y
1.68
EPS This/Next Y
-0.31
Price
6.19
Target Price
15.29
Analyst Recom
2.14
Performance Q
-23.39
Relative Volume
0.88
Beta
2.78
Ticker: NVAX
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-04-14 | NVAX | 6.41 | 0.57 | 0.07 | 264064 |
2025-04-15 | NVAX | 6.39 | 0.56 | 0.25 | 267328 |
2025-04-16 | NVAX | 6.2 | 0.56 | 1.90 | 269234 |
2025-04-17 | NVAX | 6.01 | 0.61 | 2.19 | 287934 |
2025-04-18 | NVAX | 6 | 0.61 | 1.89 | 287934 |
2025-04-21 | NVAX | 6.02 | 0.88 | 0.07 | 238902 |
2025-04-22 | NVAX | 6.26 | 0.87 | 0.87 | 240882 |
2025-04-23 | NVAX | 7.47 | 0.87 | 0.17 | 246696 |
2025-04-24 | NVAX | 7.06 | 0.81 | 0.32 | 268900 |
2025-04-25 | NVAX | 6.67 | 0.79667037066434 | 1.4936419706084 | 271635 |
2025-04-28 | NVAX | 6.705 | 0.86139139299904 | 0.56421555127146 | 266568 |
2025-04-29 | NVAX | 6.42 | 0.85 | 0.23 | 276550 |
2025-04-30 | NVAX | 6.66 | 0.84 | 0.27 | 279831 |
2025-05-01 | NVAX | 6.4 | 0.83 | 0.73 | 282065 |
2025-05-02 | NVAX | 6.41 | 0.83 | 1.60 | 286610 |
2025-05-05 | NVAX | 6.27 | 0.85 | 0.46 | 273565 |
2025-05-06 | NVAX | 6.09 | 0.85 | 1.06 | 275999 |
2025-05-07 | NVAX | 5.94 | 0.85 | 0.51 | 283413 |
2025-05-08 | NVAX | 6.64 | 0.84 | 0.14 | 286992 |
2025-05-09 | NVAX | 5.97 | 0.74 | 0.33 | 311746 |
2025-05-12 | NVAX | 6.34 | 0.74 | 0.19 | 301219 |
2025-05-13 | NVAX | 6.18 | 0.72 | 0.21 | 306529 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-04-14 | NVAX | 6.41 | 151.8 | - | 0.27 |
2025-04-15 | NVAX | 6.39 | 151.8 | - | 0.27 |
2025-04-16 | NVAX | 6.21 | 151.8 | - | 0.27 |
2025-04-17 | NVAX | 6.00 | 151.8 | - | 0.27 |
2025-04-18 | NVAX | 6.00 | 151.8 | - | 0.49 |
2025-04-21 | NVAX | 6.01 | 151.8 | - | 0.49 |
2025-04-22 | NVAX | 6.25 | 151.8 | - | 0.49 |
2025-04-23 | NVAX | 7.47 | 151.8 | - | 0.49 |
2025-04-24 | NVAX | 7.05 | 151.8 | - | 0.49 |
2025-04-25 | NVAX | 6.67 | 151.8 | - | 0.49 |
2025-04-28 | NVAX | 6.70 | 151.8 | - | 0.49 |
2025-04-29 | NVAX | 6.42 | 151.8 | - | 0.49 |
2025-04-30 | NVAX | 6.67 | 151.8 | - | 0.49 |
2025-05-01 | NVAX | 6.41 | 151.8 | - | 0.49 |
2025-05-02 | NVAX | 6.41 | 151.8 | - | 0.49 |
2025-05-05 | NVAX | 6.27 | 151.8 | - | 0.49 |
2025-05-06 | NVAX | 6.09 | 234.0 | - | 0.49 |
2025-05-07 | NVAX | 5.95 | 234.0 | - | 0.49 |
2025-05-08 | NVAX | 6.65 | 234.0 | - | 0.49 |
2025-05-09 | NVAX | 5.97 | -102.0 | - | 0.45 |
2025-05-12 | NVAX | 6.34 | -102.0 | - | 0.45 |
2025-05-13 | NVAX | 6.19 | -84.8 | - | 0.45 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-04-14 | NVAX | -0.10 | 1.96 | 25.16 |
2025-04-15 | NVAX | -0.10 | 1.96 | 25.16 |
2025-04-16 | NVAX | -0.10 | 1.96 | 25.16 |
2025-04-17 | NVAX | -0.10 | 1.96 | 25.16 |
2025-04-18 | NVAX | -0.10 | 1.96 | 25.16 |
2025-04-21 | NVAX | -0.10 | 1.68 | 25.16 |
2025-04-22 | NVAX | -0.10 | 1.68 | 25.16 |
2025-04-23 | NVAX | -0.10 | 1.68 | 25.16 |
2025-04-24 | NVAX | -0.10 | 1.68 | 25.16 |
2025-04-25 | NVAX | -0.10 | 1.68 | 25.16 |
2025-04-28 | NVAX | -0.10 | 1.68 | 27.99 |
2025-04-29 | NVAX | -0.10 | 1.68 | 27.99 |
2025-04-30 | NVAX | -0.10 | 1.68 | 27.99 |
2025-05-01 | NVAX | -0.10 | 1.68 | 27.99 |
2025-05-02 | NVAX | -0.10 | 1.68 | 27.99 |
2025-05-05 | NVAX | -0.10 | 1.13 | 27.99 |
2025-05-06 | NVAX | -0.10 | 1.13 | 27.99 |
2025-05-07 | NVAX | -0.10 | 1.13 | 27.80 |
2025-05-08 | NVAX | -0.10 | 1.13 | 27.80 |
2025-05-09 | NVAX | -0.10 | 1.13 | 27.80 |
2025-05-12 | NVAX | -0.10 | -0.65 | 28.68 |
2025-05-13 | NVAX | -0.10 | -0.65 | 28.68 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
2.93
Avg. EPS Est. Current Quarter
0.08
Avg. EPS Est. Next Quarter
-0.21
Insider Transactions
-0.1
Institutional Transactions
-0.65
Beta
2.78
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
96
Growth Score
35
Sentiment Score
81
Actual DrawDown %
98.1
Max Drawdown 5-Year %
-98.8
Target Price
15.29
P/E
2.33
Forward P/E
16.43
PEG
0.06
P/S
0.8
P/B
P/Free Cash Flow
EPS
2.65
Average EPS Est. Cur. Y
0.45
EPS Next Y. (Est.)
0.14
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
38.14
Relative Volume
0.88
Return on Equity vs Sector %
-656.5
Return on Equity vs Industry %
-639.6
EPS 1 7Days Diff
EPS 1 30Days Diff
0.18
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 952
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading